Skip to content

Online mindfulness-enhanced cognitive behavioural therapy for anxiety and depression: Outcomes of a pilot trial

Natalie Kladnitski, Jessica Simons Smith, Adrian R. Allen, Gavin J Andrews, Jill Maree Newby

Internet Interventions June 22, 2018 DOI: 10.1016/j.invent.2018.06.003 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Uncontrolled feasibility and acceptability trial Randomized Pilot study Peer reviewed
Sample size 22
Population Adults with anxiety disorders and/or major depression
Duration 7-lesson intervention over 14 weeks, with three-month post-treatment follow-up
Measures K-10, GAD-7, PHQ-9, FFMQ, WEMBWS
Topics Anxiety Depression Meditation
Citations 31
Key findings Integrating formal and informal mindfulness exercises into a transdiagnostic iCBT program was feasible and was accompanied by large reductions in distress, anxiety, and depression and improvements in mindfulness and well-being from baseline to post-treatment, maintained at three-month follow-up. However, adherence was lower than expected, with only 59.1% of participants completing treatment, and the authors state a randomized controlled trial is needed to test efficacy.

Abstract

Transdiagnostic internet-delivered cognitive behavioural therapies (iCBT) are effective for treating anxiety and depression, but there is room for improvement. In this study we developed a new Mindfulness-Enhanced iCBT intervention by incorporating formal and informal mindfulness exercises within an existing transdiagnostic iCBT program for mixed depression and anxiety. We examined the acceptability, feasibility, and outcomes of this new program in a sample of 22 adults with anxiety disorders and/or major depression. Participants took part in the 7-lesson clinician-guided online intervention over 14 weeks, and completed measures of distress (K-10), anxiety (GAD-7), depression (PHQ-9), mindfulness (FFMQ) and well-being (WEMBWS) at pre-, mid-, post-treatment, and three months post-treatment. Treatment engagement, satisfaction, and side-effects were assessed. We found large, significant reductions in distress (Hedges g = 1.55), anxiety ( g = 1.39), and depression ( g = 1.96), and improvements in trait mindfulness ( g = 0.98) and well-being ( g = 1.26) between baseline and post-treatment, all of which were maintained at follow-up. Treatment satisfaction was high for treatment-completers, with minimal side-effects reported, although adherence was lower than expected (59.1% completed). These findings show that it is feasible to integrate online mindfulness training with iCBT for the treatment of anxiety and depression, but further research is needed to improve adherence. A randomised controlled trial is needed to explore the efficacy of this program.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Cited by 5

Cites 12

and 7 more in the library

Explore topics